Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03376541

Ligand	Ligand name	Chain	PDB	Tanimoto
BUL	BULGECIN A	A	1LMC	0.78
BUL	BULGECIN A	A	1LSP	0.78
SNG	METHYL 2-ACETAMIDO-1,2-DIDEOXY-1-SELENO-BETA-D-GLUCOPYRANOSIDE	A	2BWM	0.7
SNG	METHYL 2-ACETAMIDO-1,2-DIDEOXY-1-SELENO-BETA-D-GLUCOPYRANOSIDE	A	1O9V	0.7
MLD	GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)-L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA	A,X	2F2L	0.71
MLD	GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)-L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA	A,B,C,D	2CB3	0.71
WZ4	methyl 2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->2)-alpha-D-mannopyranosyl-(1->3)-[alpha-D-mannopyranosyl-(1->6)-6-thio-alpha-D-mannopyranosyl-(1->6)]-beta-D-mannopyranoside	A	3BVW	0.72
MA8	(2S,3R,5S,6S)-2,3,4,5,6-PENTAHYDROXYCYCLOHEXYL 2-(L-CYSTEINYLAMINO)-2-DEOXY-ALPHA-L-GLUCOPYRANOSIDE	A	2C27	0.75
MNA	2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID	A	2P3I	0.7
MNA	2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID	A	1KQR	0.7
MNA	2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID	A,B,C,D,E,F	1HGH	0.7
MNA	2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID	A,B	2I2S	0.7
MNA	2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID	A	2P3J	0.7
MNA	2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID	A,B,C,D,E,F	1HGE	0.7
MNA	2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID	A	2P3K	0.7
DT6	2,4-BIS(ACETYLAMINO)-1,5-ANHYDRO-2,4-DIDEOXY-D-GLUCITOL	A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R	2HIL	0.7
DT6	2,4-BIS(ACETYLAMINO)-1,5-ANHYDRO-2,4-DIDEOXY-D-GLUCITOL	A	2HI2	0.7
AGH	N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE	A	1ZT4	0.7
AGH	N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE	A,C,E	2PO6	0.7
PBS	(2S,3S,4R)-N-OCTANOYL-1-[(ALPHA-D-GALACTOPYRANOSYL)OXY]-2-AMINO-OCTADECANE-3,4-DIOL	A,C	1Z5L	0.7
NXD	METHYL 5-(ACETYLAMINO)-9-{[AMINO(OXO)ACETYL]AMINO}-3,5,9-TRIDEOXY-D-GLYCERO-ALPHA-D-GLUCO-NON-2-ULOPYRANOSIDONIC ACID	A	2G5R	0.75
2G0	(2S)-1-[(2S)-6-amino-2-({[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]acetyl}amino)hexanoyl]-N-[(1S)-1-carbamoyl-3-methylbutyl]pyrrolidine-2-carboxamide	A,B,C,D	3DCQ	0.74
SKD	2-ACETYLAMINO-7-(1,2-DIHYDROXY-ETHYL)-3-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCTANE-5-CARBOXYLIC ACID	A	2SLI	0.71
SKD	2-ACETYLAMINO-7-(1,2-DIHYDROXY-ETHYL)-3-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCTANE-5-CARBOXYLIC ACID	A	2JKB	0.71
SKD	2-ACETYLAMINO-7-(1,2-DIHYDROXY-ETHYL)-3-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCTANE-5-CARBOXYLIC ACID	A	3SLI	0.71
AMN	9-DEOXY-9-AMINO-2-O-METHYL-5-N-ACETYL-ALPHA-D-NEURAMINIC ACID	A,B,C,D,E,F	1HGJ	0.71
ANA	4-O-ACETYL-ALPHA-2-OMETHYL-5-N-ACETYL-ALPHA-D-NEURAMINIC ACID	A,B,C,D,E,F	1HGI	0.7
SIO	methyl 4,9-di-O-acetyl-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid	A	3CL5	0.71
CLY	CLINDAMYCIN	0,1,3,9,A,B,C,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	1YJN	0.83
CLY	CLINDAMYCIN	A	1JZX	0.83
HAG	4-S-GLUTATHIONYL-5-PENTYL-TETRAHYDRO-FURAN-2-OL	A,B	1B48	0.77
PCJ	(2R)-3-{[(2S)-3-HYDROXY-2-(PALMITOYLAMINO)PROPYL]THIO}PROPANE-1,2-DIYL DIHEXADECANOATE	A,N	2Z81	0.72
PCJ	(2R)-3-{[(2S)-3-HYDROXY-2-(PALMITOYLAMINO)PROPYL]THIO}PROPANE-1,2-DIYL DIHEXADECANOATE	A,B,C	2Z7X	0.72
BLG	4-O-(4-O-SULFONYL-N-ACETYLGLUCOSAMININYL)-5-METHYLHYDROXY-L-PROLINE-TAURINE	A	1D0M	0.78
BLG	4-O-(4-O-SULFONYL-N-ACETYLGLUCOSAMININYL)-5-METHYLHYDROXY-L-PROLINE-TAURINE	A	1D0L	0.78
BLG	4-O-(4-O-SULFONYL-N-ACETYLGLUCOSAMININYL)-5-METHYLHYDROXY-L-PROLINE-TAURINE	A	1SLY	0.78
MU2	N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE	A	2IXV	0.72
MU2	N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE	A	2IXU	0.72
8GP		A	2F3U	0.7
BGN	N-BUTANOYL-2-AMINO-2-DEOXY-GLUCOPYRANOSIDE	A,B,C,D	1NWG	0.7